CharlesMalcolmClarkJr.MD

PubMed

• 37 citations
  Clinical, metabolic and psychological outcomes and treatment costs of a prospective randomized trial based on different educational strategies to improve diabetes care...
  Juan José Gagliardino, Silvia Gorbán de Lapertosa, G. Pfirter, M. Villagra, Joaquín E. Caporale
  Diabetic Medicine. 2013-09-01
• 8 citations
  Peer support in diabetes management -- toward global application. Overview.
  Charles M. Clark
  Family Practice. 2010-06-01
• 15 citations
  Comparison of clinical-metabolic monitoring and outcomes and coronary risk status in people with type 2 diabetes from Australia, France and Latin America.
  Juan José Gagliardino, Line Kleinebreil, Stephen Colagiuri, Jeff R. Flack, Joaquín Caporale
  Diabetes Research and Clinical Practice. 2010-04-01

Journal Articles

• Type 2 diabetes patients educated by other patients perform at least as well as patients trained by professionals.  
  Gagliardino JJ, Arrechea V, Assad D, Gagliardino GG, Gonzalez S, Lucero S, Rizzuti L, Zufriategui Z, Clark CM Jr, Diabetes/Metabolism Research and Reviews, 2/1/2013
• Effectiveness of Staged Diabetes Management on the Quality of Diabetes Care in Mexico.  
  Rodriguez-Saldana J, Morales de Teresa MA, Rosales-Campos AC, Clark Jr. CM, Mazze RS, Strock E, Practical Diabetes International, 7/1/2010
• Comparison of clinical-metabolic monitoring and outcomes and coronary risk status in people with type 2 diabetes from Australia, France and Latin America.  
  Gagliardino JJ, Kleinebreil L, Colagiuri S, Flack J, Caporale JE, Siri F, Clark CM Jr, Diabetes Research and Clinical Practice, 3/1/2010
• Predictors of perceived risk of the development of diabetes.  
  Gallivan J, Brown C, Greenberg R, Clark C, Diabetes Spectrum, 1/1/2009
• A patient-centered treatment program for type 2 diabetes and associated cardiovascular risk factors in the city of Corrientes, Argentina. Study design and baseline data.  
  Gagliardino JJ, Lapertosa S, Villagra M, Caporale JE, Oliver P, Gonzalez C, Siri F, Clark C , on behalf of the PRODIACOR participating members, Contemporary Clinical Trials, 7/1/2007
• Development and Implementation of Advanced Training Course for Diabetes Educators in Argentina.  
  Gagliardino JJ, del Carmen Malbran M, Clark CM, Diabetes Spectrum, 1/1/2007
• Prevention and early identification of type 2 diabetes in adults: An update from the National Diabetes Education Program.  
  Clark CM, Gavin JR, Blonde L, Warren-Boulton E, Behavioral Health Trends, 12/1/2006
• Prevention and early identification of type 2 diabetes in adults: an update from the National Diabetes Education Program.  
  Clark CM, Gavin JR III, Blonde L, Warren-Boulton E, Drug Benefit Trends, 10/1/2005
• Prevention and Early Identification of Type 2 Diabetes in Adults: an Update. From the National Diabetes Education Program.  
  Clark CM, Gavin JR, Blonde L, Warren-Boulton E, Diabetes Trends, 10/1/2005
• Staged Diabetes Management in Mexico: optimizing care with limited resources.  
  Rodriguez-Saldana J, Jonguitud-Falcon A, Clark CM, Escorza-Dominguez AB, Morales de Teresa M, Ortiz-Gress AA, Diabetes Voice, 12/1/2003
• Diabetes and Heart Disease: An Evidence-Driven Guide to Risk Factors Management in Diabetes.  
  Amale A, Lteif MD, Kieren J, Mather MD, Charles M, Clark MD, Cardiology in Review, 9/1/2003
• A systematic approach to risk stratification and intervention within a managed care environment improves diabetes outcomes and patient satisfaction.  
  Clark CM, Snyder JW, Meek RL, Stutz LM, Parkin CG, Diabetes Care, 6/1/2001
• Incorporating the results of diabetes research into clinical practice: celebrating 25 years of diabetes research and training center translation research.  
  Clark CM, Chin MH, Davis SN, Fisher E, Hiss RG, Marrero DG, Walker EA, Wylie-Rosett J, Diabetes Care, 1/1/2001
• Basal Insulin Therapy in Type 2 Diabetes. 28-week comparison of insulin glargine (HOE 901) and NPH insulin.  
  Rosenstock J, Schwartz SL, Clark CM, Park GD, Donley DW, Edwards MB, Diabetes Care, 1/1/2001
• Using Hospitalization Rates to Track the Economic Costs and Benefits of Improved Diabetes Care in the Americas. A proposal for health policy makers.  
  Gagliardino JJ, Williams R, Clark CM, Diabetes Care, 1/1/2000
• What We Can Learn From Argentina.  
  Clark CM, Diabetes Care, 1/1/2000
• Promoting early diagnosis and treatment of type 2 diabetes: the National Diabetes Education Program.  
  Clark CM, Fradkin JE, Hiss RG, Lorenz RA, Vinicor F, Warren-Boulton E, JAMA, 1/1/2000
• Prevention of the Microvascular Complications in Type 2 Diabetes.  
  Clark CM, Diabetes Trends, 1/1/2000
• Combating Sloth as Well as Gluttony: The Role of Physical Fitness in Mortality among men with Type 2 Diabetes.  
  Clark CM, Annuals of Internal Medicine, 1/1/1999
• Type 2 diabetes and macrovascular disease: Epidemiology and etiology.  
  Clark CM, Perry RC, Am Heart J, 1/1/1999
• Reducing the Burden of Diabetes: Managing Cardiovascular Disease.  
  Keen H, Clark CM, Laakso M, Diabetes/Metabolism Research and Reviews, 1/1/1999
• Diabetes Clinic commentary (editorial).  
  Clark CM, Cardiology Review, 1/1/1999
• The National Diabetes Education Program: Changing the Way Diabetes is Treated.  
  Clark CM, Annuals of Internal Medicine, 1/1/1999
• Reducing the Burden of Diabetes  
  Clark CM, Diabetes Care, 1/1/1998
• The Effect of Intensive Diabetes Therapy on Measures of Autonomic Nervous System Function in The Diabetes Control and Complications Trial.  
  Clark CM Jr, The Diabetes Control and Complications Trial Research Group - (Chairman; Data, Safety & Quality Review Group), Diabetologia, 1/1/1998
• Join now to see all

Books/Book Chapters

• Family Practice 
  Chapter: Overview 
  Page 3 - 5Clark CM Jr2010
• The DOTA Education Task Group Standards and Norms for Diabetes Education Programs For People with Diabetes in the Americas. 
  Clark CM Jr2000
• American Diabetes Association: Physician’s Guide to Insulin-Dependent (Type n Diabetes. Diagnosis and Treatment 
  Clark CM Jr1988
• American Diabetes Association: The Physician’s Guide to Type 11 Diabetes (NIDDM). Diagnosis and Treatment, 
  Clark CM Jr1984
• National Diabetes Advisory Board: The Prevention and Treatment of Five Complications of Diabetes: A Guide for Primary Care Practitioners. 
  Clark CM JrUS Department of Health & Human Services1983
• Biochemical Development of the Fetus and Neonat 
  Chapter: The growth and metabolism of the developing rat heart. 
  Page 185 - 212Clark J, Clark CMEditors: Colin T. Jones.Elsevier Biomedical Press1982
• Early Diabetes in Early Life 
  Chapter: Development of hormone receptors in the isolated fetal rat heart. 
  Page 105 - 114Vinicor F, Clark J, Clark CM JrEditors: Rafael A, Camerine-Davalors.Academic Press1975
• Clinical Aspects of Metabolic Bone Disease 
  Chapter: Derivation and significance of urinary cyclic AMP in man. 
  Page 67 - 73Bell NH, Frideman HR, Clark CM Jr., Allen DOEditors: Frame B, Parfitt AM, Duncan H.Excerpta Medica, Amsterdam1973
• Join now to see all

Abstracts/Posters

• Early Termination of the Diabetes Control and Complications Trial.
  Lachin JM, Cleary, P, Crofford O, Genuth S, Nathan D, Clark C, Ferris F, Siebert C, for the DCCT Research Group, Data Monitoring in Clinical Trials, 1/1/2006
• An Educational Approach to Diabetes Mellitus in Digestive (CADIEQ) International Diabetes Federation
  Clark CM Jr, The CADIEQ Committee, Mexico City NDC, 1/1/2000
• The United States of America’s National Diabetes Education Program (NDEP).
  Clark CM and the NDEP Steering Committee, Diabetologia, 1/1/1997
• A new approach to continuing medical education: Impact on physician behavior and patient outcomes.
  Moore P, Marrero D, Langefeld C, Clark CM, Diabetes, 1/1/1991
• Do community physicians adhere to ADA treatment guidelines?
  Marrero D, Moore P, Fineberg N, Moorman N, Clark C, Wilson M, Diabetes, 1/1/1989
• The results of the long-term open-label administration of Alredase (Tolrestat) in the treatment of diabetic neuropathy.
  Koglin L, Clark C, Ryder S, Mullane JF, Diabeta, 1/1/1985
• Persistence of effects of physician education on diabetes care practices.
  Mazzuca SM, Clark CM, Diabeta, 1/1/1983
• A controlled clinical trial of the effects of patient and physician education on diabetic patient outcomes.
  Vinicor F, Cohen S, Mazzuca S, Clark CM, Diabeta, 1/1/1983
• Evaluating diabetes instruction for physicians by changes in practice.
  Mazzuca SM, Clark CM Jr, Diabeta, 1/1/1982
• An analysis of the costs and benefits of a vaccination and screening program to prevent insulin-dependent diabetes mellitus.
  England WL and Roberts SD (Spon: C M Clark, Jr.), Clin Res, 1/1/1980
• Characterization and significance of hepatic receptors for insulin during fetal and neonatal life.
  Vinicor F, Clark CM Jr, Diabeta, 1/1/1980
• Multiple factors found associated with abnormal nerve conduction velocity (NCV) in adult diabetics.
  Kuebler TW, Markand ON, Norton JA Jr, ., Fineberg SE, Vinicor F, Clark CM Jr, Clin Res, 1/1/1980
• Evidence for modulation of adenylate cyclase by guanyl nucleotides (GN) in the developing rat heart.
  Clark JB, Vinicor F, Clark CM Jr, Clin Res, 10/1/1977
• Rat heart adenylyl cyclase activity during postnatal development: Effects of glucagon and 5’-guanylylimidodiphosphate.
  Yount EA, Clark CM Jr., (Spon: Julia F. Clark), Federation Proceedings, 3/1/1976
• Effects of guanosine triphophate (GTP) on the ontogenesis of rat cardiac adenylate cyclase
  Vinicor F, Wills S, Clark CM Jr, Clin Res, 1/1/1976
• Insulin binding to heart cells isolated from adult and newborn rats.
  Clark JF, Clark CM Jr, Clin Res, 1/1/1975
• Spontaneous development of a glucagon-sensitive adenylate cyclase system in cultured
  Vinicor F, Kohalmi D, Clark CM Jr., Clin Res, 1/1/1975
• Suitability of isolated rat heart cells for studies on the mechanism of hormone action.
  Clark JF, Clark CM Jr., Vinicor F, Diabetes, 1/1/1975
• Development of glucagon sensitivity in neonatal rat liver.
  Vinicor F, Higdon G, Clark JF, Clark CM Jr, Diabetes, 1/1/1975
• Evidence that cyclic AMP does not mediate the inotropic and chronotropic effects of glucagon in the fetal mouse heart.
  Clark CM Jr., Allen DO, Wakeland JR, Wildenthal K, Clin Res, 1/1/1975
• Biological activity of monolodinated glucagon in rat liver.
  Vinicor F, Fricke R, Clark CM Jr, Clin Res, 1/1/1974
• Studies on the mechanism of action of glucagon in the adult mouse heart.
  Vinicor F,Waller D, Kohalmi D, Clark CM Jr, Allen DO, Yount E, Levey G, Wildenthal K, Clin Res, 1/1/1974
• Studies on species in the development of myocardial hormone receptors in tissue
  Vinicor F, Kohalmi D, Clark CM Jr, Clin Res, 1/1/1974
• The effects of alloxan diabetes on fetal myocardial and hepatic glycogen storage in the rat.
  Vinicor F, Kohalmi D, Clark CM Jr, Clin Res, 1/1/1973
• The inheritance of glucose to tolerance as a quantitative variable.
  Bader PI, Bingle Gl, Yu PL, Clark CM Jr, Nance WE, Am J Hum Gen, 1/1/1973
• Join now to see all

Lectures

• Glimepiride: dose-regimen and dose-response studies 
  Leadership Forum: Type II Diabetes. Roundtable Proceedings. - 1/1/1996
• Characterization and significance of hepatic receptors for insulin during fetal and neonatal life. 
  Presented at 40th Annual Meeting, American Diabetes Association, Washington, DC - 6/1/1980
• Physicians’ beliefs as predictors of their clinical intentions. 
  Annual Meeting of the American Education Research Association, Boston, MA - 1/1/1980
• Characterization of glucose metabolism in the isolated rat heart during fetal and neonatal development. 
  Congress of the International Diabetes Federation, Brussels, Belgium - 7/1/1973
• Join now to see all

Other

• Effective Diabetes Management in a Primary Care Setting. 
  Clark CM Jr
  CD-ROM Indiana University School of Medicine Division of Continuing Medical Education - 1/1/2000